MDXG Buyback

MiMedx Group, Inc. Buyback

OLI recorded this information on 10/9/2017

Company:

MiMedx Group, Inc.

Buyback:

MDXG buyback

$Amount Authorized:

$110,000,000

Buyback Details:

MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of healthcare, announced today the decision of its Board of Directors to authorize a $10 million increase in the Company's Share Repurchase Program. This action by the MiMedx Board of Directors authorizing the additional $10 million to the Company's Share Repurchase Program brings the total authorized to $110 million since the Share Repurchase Program commenced in May 2014. The Company reported that in light of the short seller attacks and its strong balance sheet and cash flows, the MiMedx Board of Directors believes the stock repurchases continue to be an extremely positive investment for MiMedx. The Board also agreed to review this program again at its scheduled meeting on October 26, 2017, and to consider an additional commitment at that time.

MiMedx Group is a placental biologics company, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. Co. is focused on wound care, surgical recovery applications, and musculoskeletal conditions. Co. derives its products from human placental tissues and process these tissues using its proprietary methods, including the PURION® process. Co. provides products primarily for use in the wound care, burn, and surgical recovery sectors of healthcare. Co. is a supplier of human placental allografts, which are human tissues that are derived from the donor and used to produce products that treat the recipient.

MDXG SEC Filing Email Alerts Service

Open the MDXG Page at The Online Investor »

MDXG — Key Stats (updated Fri., May. 10, 10:39 AM)

Company Name:	MiMedx Group Inc
Stock buyback:	MDXG buyback
Website:	www.mimedx.com
Sector:	Biotechnology
Number of ETFs Holding MDXG:	20
Total Market Value Held by ETFs:	$92.49M
Total Market Capitalization:	$1.06B
% of Market Cap. Held by ETFs:	8.74%

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.

MiMedx Group, Inc. Buyback

MDXG Buyback | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved